| Kristi Kay Wilde, PT | |
|
101 West Crook Street, Moorcroft, WY 82721 | |
| (307) 756-9200 | |
| Not Available |
| Full Name | Kristi Kay Wilde |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 33 Years |
| Location | 101 West Crook Street, Moorcroft, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366923104 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT-0350 (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Davis Outpatient Therapy Llc | 7113317330 | 4 |
| Hand Therapy Of Wyoming Llc | 7416233259 | 14 |
News Archive
Joan Broderick, Ph.D., Research Associate Professor, Department of Psychiatry and Behavioral Sciences at Stony Brook University, has received a $606,000 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.
When one of Cindy Holtzman's clients told the Woodstock, Ga., broker he was considering dropping his Affordable Care Act plan because next year's cost approached $23,000 for his family of four, she suggested a new option: a back-to-back set of four, 90-day short-term plans, which would effectively give them a modicum of medical coverage for 2018.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have discovered that deficiency of a single protein, Mitofusin 2, in muscle and hepatic cells of mice is sufficient to cause tissues to become insensitive to insulin, thus producing an increase in blood glucose concentrations. These are the two most common conditions prior to development of diabetes type 2.
› Verified 9 days ago
| Provider Name | Hand Therapy Of Wyoming Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1083155972 PECOS PAC ID: 7416233259 Enrollment ID: O20170411000826 |
News Archive
Joan Broderick, Ph.D., Research Associate Professor, Department of Psychiatry and Behavioral Sciences at Stony Brook University, has received a $606,000 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.
When one of Cindy Holtzman's clients told the Woodstock, Ga., broker he was considering dropping his Affordable Care Act plan because next year's cost approached $23,000 for his family of four, she suggested a new option: a back-to-back set of four, 90-day short-term plans, which would effectively give them a modicum of medical coverage for 2018.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have discovered that deficiency of a single protein, Mitofusin 2, in muscle and hepatic cells of mice is sufficient to cause tissues to become insensitive to insulin, thus producing an increase in blood glucose concentrations. These are the two most common conditions prior to development of diabetes type 2.
› Verified 9 days ago
| Provider Name | Davis Outpatient Therapy Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1972268431 PECOS PAC ID: 7113317330 Enrollment ID: O20211202001217 |
News Archive
Joan Broderick, Ph.D., Research Associate Professor, Department of Psychiatry and Behavioral Sciences at Stony Brook University, has received a $606,000 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.
When one of Cindy Holtzman's clients told the Woodstock, Ga., broker he was considering dropping his Affordable Care Act plan because next year's cost approached $23,000 for his family of four, she suggested a new option: a back-to-back set of four, 90-day short-term plans, which would effectively give them a modicum of medical coverage for 2018.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have discovered that deficiency of a single protein, Mitofusin 2, in muscle and hepatic cells of mice is sufficient to cause tissues to become insensitive to insulin, thus producing an increase in blood glucose concentrations. These are the two most common conditions prior to development of diabetes type 2.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kristi Kay Wilde, PT Po Box 338, Moorcroft, WY 82721-0338 Ph: (307) 756-9200 | Kristi Kay Wilde, PT 101 West Crook Street, Moorcroft, WY 82721 Ph: (307) 756-9200 |
News Archive
Joan Broderick, Ph.D., Research Associate Professor, Department of Psychiatry and Behavioral Sciences at Stony Brook University, has received a $606,000 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health.
When one of Cindy Holtzman's clients told the Woodstock, Ga., broker he was considering dropping his Affordable Care Act plan because next year's cost approached $23,000 for his family of four, she suggested a new option: a back-to-back set of four, 90-day short-term plans, which would effectively give them a modicum of medical coverage for 2018.
Viron Therapeutics Inc., a biotechnology company pioneering the development of immune-modulating protein therapeutics derived from pathogens, today reported results from a Phase IIa clinical trial evaluating VT-111 (Serp-1), an anti-inflammatory protein derived from the myxoma virus.
Researchers at the Institute for Research in Biomedicine (IRB Barcelona) have discovered that deficiency of a single protein, Mitofusin 2, in muscle and hepatic cells of mice is sufficient to cause tissues to become insensitive to insulin, thus producing an increase in blood glucose concentrations. These are the two most common conditions prior to development of diabetes type 2.
› Verified 9 days ago
Cody Camp, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 101 West Crook Street, Moorcroft, WY 82721 Phone: 307-756-9200 | |
Casey Michelle Sutton, Physical Therapist Medicare: Medicare Enrolled Practice Location: 116 N Little Horn Ave, Moorcroft, WY 82721 Phone: 307-756-3344 | |
Mikaela Schwantz, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 116 N Little Horn Ave, Moorcroft, WY 82721 Phone: 307-756-3344 |